ArticleGeroScience2026
Emergence of heartbeat frailty in advanced age II: individual cardiovascular aging trajectories revealed by lifelong echocardiography in male mice.
Article in GeroScience, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Chronological age is the strongest risk factor for cardiovascular disease, yet individual trajectories of cardiovascular aging, particularly during late life, remain incompletely characterized. We performed quarterly echocardiography in 58 male C57BL/6 mice from 6 months until natural death, focusing on long-lived mice surviving beyond the cohort median of 24 months. Progressive body weight loss after 18-21 months defined the frailty transition and partitioned each mouse's lifespan into pre-frailty and frailty phases. Pulse wave velocity increased 15% across the lifespan, accompanied by luminal dilatation and declining fractional diameter change in all arterial segments, confirming arterial stiffening as a primary aging process. Left ventricular mass increased continuously, even as body weight declined, transitioning from concentric hypertrophy (wall thickening without chamber dilatation) in pre-frailty to eccentric hypertrophy (wall thickening plus chamber dilatation) in frailty. Ejection fraction declined from 51 to 27%; partial stroke volume preservation was achieved through Frank-Starling compensation. Heart rate increased during pre-frailty then declined during frailty, correlating with body weight loss rate. Critically, inter-individual variability in rates of change increased 2-threefold during frailty for all cardiac and arterial parameters despite genetic homogeneity and controlled housing, implicating stochastic mechanisms, including epigenetic drift, mitochondrial dysfunction, and heterogeneous senescent burden, as dominant determinants of late-life trajectories. These findings parallel human cardiovascular aging patterns and identify the frailty transition as a critical inflection point at which myocardial compensation yields to decompensation and individual divergence amplifies.
Indexed as
Identifiers
42406280What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.